23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.15%
Negative revenue growth while Insurance - Life median is 0.00%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-4.90%
Negative gross profit growth while Insurance - Life median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.
12.13%
EBIT growth 1.25-1.5x Insurance - Life median of 10.19%. Mohnish Pabrai would see if the advantage stems from superior cost management or product pricing.
12.13%
Operating income growth near Insurance - Life median of 12.13%. Charlie Munger might chalk it up to standard industry trends.
17.07%
Net income growth near Insurance - Life median of 17.07%. Charlie Munger would see common industry factors at play.
17.06%
EPS growth 1.25-1.5x Insurance - Life median of 13.79%. Mohnish Pabrai would see if the company’s capital allocation strategy boosts these results.
17.08%
Diluted EPS growth near Insurance - Life median of 15.79%. Charlie Munger would expect typical industry-level share usage and profit trends.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
138.08%
OCF growth of 138.08% while Insurance - Life is zero. Walter Schloss might see a modest positive difference, which can compound over time.
138.08%
FCF growth of 138.08% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
118.14%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 48.85%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
80.78%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 31.04%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
-5.41%
Negative 3Y CAGR while Insurance - Life median is 0.00%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
No Data
No Data available this quarter, please select a different quarter.
99.99%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 6.61%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
-15.04%
Negative 3Y OCF/share CAGR while Insurance - Life median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
400.78%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 161.62% over a decade. Joel Greenblatt might see a standout compounder of earnings.
159.39%
5Y net income/share CAGR > 1.5x Insurance - Life median of 60.45%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
19.62%
3Y net income/share CAGR of 19.62% while Insurance - Life median is zero. Walter Schloss might see a small advantage that can be scaled further.
No Data
No Data available this quarter, please select a different quarter.
156.95%
5Y equity/share CAGR > 1.5x Insurance - Life median of 13.05%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
3.71%
3Y equity/share CAGR > 1.5x Insurance - Life median of 1.06%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
AR shrinking while Insurance - Life median grows. Seth Klarman sees potential advantage unless it signals declining demand.
No Data
No Data available this quarter, please select a different quarter.
-1.23%
Assets shrink while Insurance - Life median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
-1.04%
Negative BV/share change while Insurance - Life median is -0.34%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
154.30%
Debt growth of 154.30% while Insurance - Life median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
128.70%
SG&A growth of 128.70% while Insurance - Life median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.